| Name | Title | Contact Details |
|---|
DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.
Pronger Smith Medical Care's 60 year tradition of trust and service offers you and your family a unique approach to health care. We are fully equipped to provide a lifetime of comprehensive and accessible care-all under one roof. This continued effort
Crest Services inc is a Coppell, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
De Kroyft-Metz is a Peoria, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PCS Medical Solutions is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.